Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Bexarotene inhibits the viability of non-small cell lung cancer cells via slc10a2/PPARγ/PTEN/mTOR signaling pathway

Fig. 1

The construction and identification of slc10a2 overexpressed A549 cells. a The immunofluorescence staining showed slc10a2 gene had successfully transfected into 293 T cells; b The immunofluorescence staining showed slc10a2 overexpressed A549 cells were successfully constructed; c The expression of slc10a2 was significant higher in slc10a2 overexpressed A549 cells than in A549 cells; d Slc10a2-shRNA can effectively inhibit the expression of slc10a2 in A549 cells. All experiments were repeated 3 times

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us